Evidence map›Paper›PMID 37540817›Full record

ArticleJCO clinical cancer informatics2023

Information Technology and Telemedicine Services in Community Oncology Practices.

Kah Poh Loh, Ying Wang, Sule Yilmaz, Chandylen L Nightingale, Susan K Parsons, Christa Braun-Inglis, Umang Gada, Alexander Montes, Allison Magnuson, Eva Culakova and 7 more

Open access · greenAbstract read
In one paragraph

Article in JCO clinical cancer informatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Distress screening and management for adolescents and young adults: 2022 NCI community oncology program landscape assessment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Kah Poh LohDivision of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.ORCID 0000-0002-6978-0418
Ying WangDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY.
Sule YilmazDepartment of Surgery, Supportive Care in Cancer, University of Rochester Medical Center, Rochester, NY.ORCID 0000-0002-6663-9291
Chandylen L NightingaleDepartment of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston Salem, NC.ORCID 0000-0002-2275-9849
Susan K ParsonsDepartments of Medicine and Pediatrics, Tufts University School of Medicine, Boston, MA.ORCID 0000-0003-0282-6490
Christa Braun-InglisUniversity of Hawaii Cancer Center/Hawaii Minority/Underserved NCORP, Honolulu, HI.ORCID 0000-0003-0051-5533
Umang GadaDepartment of Surgery, Supportive Care in Cancer, University of Rochester Medical Center, Rochester, NY.
Alexander MontesDepartment of Surgery, Supportive Care in Cancer, University of Rochester Medical Center, Rochester, NY.
Allison MagnusonDivision of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.ORCID 0000-0002-0968-8265
Eva CulakovaDepartment of Surgery, Supportive Care in Cancer, University of Rochester Medical Center, Rochester, NY.ORCID 0000-0002-9852-6515
Sarah StrauseDepartment of Surgery, Supportive Care in Cancer, University of Rochester Medical Center, Rochester, NY.
Charles KamenDepartment of Surgery, Supportive Care in Cancer, University of Rochester Medical Center, Rochester, NY.ORCID 0000-0002-4219-4320
Emily DresslerDivision of Public Health Sciences, Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston Salem, NC.
Karen MustianDepartment of Surgery, Supportive Care in Cancer, University of Rochester Medical Center, Rochester, NY.ORCID 0000-0002-6054-7839
Gary MorrowDepartment of Surgery, Supportive Care in Cancer, University of Rochester Medical Center, Rochester, NY.
Supriya MohileDivision of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
Landscape Committee
University of Rochester Medical Center · USWake Forest University · USTufts University · USUniversity of Hawaiʻi at Mānoa · US

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Wake Forest NCORP Research BaseUG1CA189824 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Emily Van Meter Dressler, GLENN J LESSER · 2014 to 2026
$57.9M
The Hawaii NCORPUG1CA189804 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Jared Acoba, Jeffrey Lee Berenberg · 2014 to 2026
$15.7M
Clinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, Gary R Morrow · 2019 to 2026
$2.7M
A Patient-Oriented Research Program in Geriatric OncologyK24AG056589 · NIA · UNIVERSITY OF ROCHESTER · PI Supriya G. Mohile · 2018 to 2026
$1.5M
A novel mobile health exercise intervention for older patients with myeloid neoplasmsR00CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2021 to 2023
$747k
Epigenetic markers, functional status, and exercise in older adults with myeloid neoplasmsR03AG073985 · NIA · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2022 to 2023
$308k
NCI NIH HHS R00 CA237744NCI NIH HHS T32 CA102618NCI NIH HHS UG1 CA189804NCI NIH HHS UG1 CA189824NCI NIH HHS UG1 CA189961NIA NIH HHS K24 AG056589NIA NIH HHS R03 AG073985
6 · The paper itself

Abstract

purposeWe described information technology support and use of telemedicine for cancer care and research purposes at community oncology practices within the National Cancer Institute Community Oncology Research Program (NCORP).

methodsWe used data from the NCORP 2017 and 2022 Landscape Assessments. Separate logistic regression models were used to assess factors associated with the use of telemedicine for delivery of cancer care in 2017 and for research purposes in 2022 (cancer care delivery not assessed in 2022).

resultsInformation was available from 210 and 259 practice groups excluding pediatric-only groups in 2017 and 2022, respectively. In 2017, 30% of practice groups used telemedicine for delivery of cancer care; half of these (15% overall) could use telemedicine for research purposes. In 2022, telemedicine was used for research purposes in 73% of practice groups. In multivariable models, self-identifying as a safety-net hospital was associated with a lower odd of telemedicine use for delivery of cancer care (adjusted odds ratio [AOR], 0.39; 95% CI, 0.17 to 0.93), whereas affiliation with a designated critical access hospital was associated with a higher odd of telemedicine use for delivery of cancer care (AOR, 2.29; 95% CI, 1.10 to 4.76). Having a general survivorship clinic (AOR, 1.92; 95% CI, 1.04 to 3.54) and number of oncology providers (increase per 10 providers; AOR, 1.32; 95% CI, 1.05 to 1.65) were associated with telemedicine use for research purposes.

conclusionAlmost one third of NCORP practice groups used telemedicine for cancer care delivery in 2017. In 2022, there is high capacity among NCORP practices (almost three-quarters) to use telemedicine for research purposes, especially among practices with a general survivorship clinic and a greater provider number.

Indexed as

NeoplasmsTelemedicineChildDelivery of Health CareHumansInformation TechnologyMedical Oncology

Identifiers

PMID37540817
PMCPMC10569779
OpenAlexW4385567825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.